| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | n/a | (12.34) | (10.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | n/a | (24.69) | (14.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (21.90) | (11.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (0.83) | (0.30)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (23.46) | (7.10)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Notice of Full Year Results and Invest... | 20-Mar-2026 | 07:00 | Business Wire |
| Update on Voluntary Delisting from the TSX Ventu... | 19-Mar-2026 | 07:00 | Business Wire |
| Net Asset Value(s) | 16-Feb-2026 | 07:10 | RNS |
| Amaroq delisting from TSX-V to take effect | 19-Mar-2026 | ShareCast |
| Amaroq sets out fresh production guidance | 25-Feb-2026 | ShareCast |
| HealthMark Group Expands Digital Access to Medic... | 12-Feb-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 95.00p |
| Change Today | 1.00p |
| % Change | 1.06 % |
| 52 Week High | 149.00 |
| 52 Week Low | 63.00 |
| Volume | 510,984 |
| Shares Issued | 465.44m |
| Market Cap | £442.17m |
| Beta | 0.00 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:24 | 15,000 @ 94.63p |
| 16:38 | 10,000 @ 95.00p |
| 14:25 | 100,000 @ 95.50p |
| 16:30 | 1,038 @ 95.80p |
| 16:26 | 4,347 @ 95.33p |
| CEO | Eldur Ólafsson |
| CFO | Ellert Arnarson |
You are here: research